PEN Semaglutide 5mg Hilma Biocare

PEN Semaglutide 5mg Hilma Biocare is a modern pharmaceutical solution based on semaglutide, the active substance also used in the original medication Ozempic. It belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1) and is used for the treatment of type 2 diabetes, weight management, and prevention of metabolic disorders. The mechanism of action is based on stimulating insulin secretion in response to increased glucose levels, reducing excessive glucagon production, and slowing down gastric emptying, which helps decrease appetite and maintain stable blood sugar levels.

Main Benefits of PEN Semaglutide 5mg

• Effective appetite control — reduces hunger and food cravings
• Stabilizes blood sugar levels in patients with type 2 diabetes
• Improves insulin sensitivity and overall glucose metabolism
• Supports gradual and sustainable weight loss
• Proven to reduce the risk of cardiovascular complications, as confirmed by Ozempic clinical trials
• Convenient pen-injector format with pre-attached sterile needles for safe and painless administration

This product is particularly recommended for individuals with obesity (BMI ≥ 30) and overweight patients (BMI ≥ 27) who also suffer from comorbidities such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea. It is also suitable for athletes and individuals aiming to control their weight and improve metabolic health.

Pharmacological Action

Semaglutide is an analogue of the human GLP-1 hormone that regulates glucose metabolism. It stimulates insulin release in a glucose-dependent manner, prevents excessive glucagon secretion, and slows gastric emptying. This leads to appetite suppression, improved control over food intake, and gradual weight reduction. In clinical studies of Ozempic, patients achieved an average weight loss of 5–15% during long-term treatment.

How to Use

The therapy starts with a low dose (0.25 mg per week) to minimize the risk of side effects and is gradually increased. The standard therapeutic dose for weight and blood sugar control is around 2.4 mg per week. The drug is administered subcutaneously once a week into the abdomen, thigh, or upper arm. The minimum treatment duration is 16 weeks, while more significant results require a longer course.

Possible Side Effects

• Nausea, vomiting, diarrhea, or constipation
• Headache and dizziness
• Temporary weakness or fatigue
• Rarely — hypoglycemia when combined with other antidiabetic agents

According to Ozempic studies, most side effects occur at the beginning of therapy and diminish as the body adapts. Medical supervision and dosage adjustments can significantly reduce the risks.

Safety and Storage

PEN Semaglutide 5mg Hilma Biocare is manufactured under strict international quality standards. Each unit undergoes authenticity and sterility checks. The product should be stored in a refrigerator at +2…+8 °C and must not be frozen. It can also be kept at room temperature for up to 21 days, making transportation more convenient. Keep out of reach of children and store in original packaging.

Product Data